the countdown to the BioRN Annual Conference 2021 started. With high speed we are finalising the preparation to welcome you this Friday in Heidelberg for „Novel therapeutics - Biotechnology leading the way into the future”. We have put together an exceptional line-up of speakers and we are allowing plenty of networking. (register here)
Last week, Minister-President Winfried Kretschmann stopped by in Heidelberg with Franziska Brantner, member of German Parliament and Min. Theresia Bauer to discuss with the local biotech industry in our cluster. "(...) we can see in the BioRN Cluster that biotechnology is making huge progress - and we can see how important it is to link up the relevant stakeholders (...)" said the Minister President during his visit. (Press Release)
We are also excited to announced that a fourth major sponsor is supporting the launch of the upcoming BioLabs-Heidelberg co-working lab facility. BioLabs Global today announces that AbbVie has become a Gold Sponsor of BioLabs’ latest European location in Heidelberg. (Press Release)
This month, BioRN and the region were also covered in different media. In the Plattform Life Sciences // Biotechnologie - Heidelberg was reported as a German hot spot where translation is becoming a "mission possible" (in German) [more]. And our regional initiatives to attract new start-ups and support their growth have been described recently also in an article in the FAZ - Frankfurter Allgemeine (in German) [more].
Enjoy the read!
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
Minister-President Winfried Kretschmann in conversation with the regional biotech scene Minister-President Winfried Kretschmann stopped by in Heidelberg with Franziska Brantner, member of German Parliament and Min. Theresia Bauer. Picture: Florian Freundt [more]
Looking forward to get back together... Keynotes: “Next generation Immunotherapy” Holger Kissel, BioNTech SE & “Development of Bulevirtide/Hepcludex®, the first approved medication to treat chronic Hepatitis D infections.” Stephan Urban, Heidelberg University Hospital. [more]
Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101[more]
Heidelberg University:
Successful Placement in Times Higher Education Rankings [more]
Heidelberg research group seeks and develops inhibitors against flavi- and coronaviruses[more]
Heidelberg scientists create retina from stem cells of bony fish [more]
NMI:Human mini-organs in plastic chips enable testing of novel therapeutic approaches in ophthalmology[more]
02 | New BioRN Members
Phialogics, a spin-off of the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, is a preclinical biotech company dedicated to the development of therapeutics to treat patients with autoimmune diseases. The company’s expertise combines cutting edge protein engineering technology with a deep understanding of the human immune system. Company’s focus is on autoimmune disorders with high unmet medical need in order to make a difference for patients and their families.[more]
03 | BioRN Lounge 2021
BioRN Lounge - 26 September 2021
COMING BACK on site!!! Invitation and details will be sent out soon!
04 | Funding - Research Grants
+++ Boehringer Ingelheim Innovation Prize +++
'Golden Ticket’–a voucher which represents prepaid rent for one reserved bench in Biolabs shared laboratory space in Heidelberg, Germany for one year.
Deadline: October 11 [more]
BMBF - Modeling the spread of infectious diseases[more] BMBF - Multidisciplinary projects for personalized medicine[more] BMBF - Eurostars 3 funding for innovative SMEs[more] European Innovation Council EIC launched:
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
